| Literature DB >> 30057896 |
Romina Romero1, Pablo R Salgado2, César Soto3, David Contreras3,4, Victoria Melin4.
Abstract
1,2-dihydroxybenzenes (DHBs) are organic compounds which are widely studied as they are applied to advanced oxidation processes (AOPs). These compounds are also related to the development of oxidative stress, wood biodegradation, and neuronal disease in humans. DHBs are metal ligands with pro-oxidant and antioxidant properties. These activities are related to their chelation properties and a consequence of the deprotonation of their hydroxyl groups. In literature, there are several pKa values for the hydroxyl groups of DHBs. These values vary depending on the experimental conditions or the algorithm used for calculation. In this work, an experimentally validated computational method was implemented in aqueous solution for pKa determination of 24 DHBs. The deprotonation order of the hydroxyl groups in DHB was determined observing a selective deprotonation, which depended on the ability of the substituent to donate or withdraw electron density over the ring.Entities:
Keywords: Hammett constant and acidity constant; catecholamines; catechols; dihydroxybenzene; pKa
Year: 2018 PMID: 30057896 PMCID: PMC6053874 DOI: 10.3389/fchem.2018.00208
Source DB: PubMed Journal: Front Chem ISSN: 2296-2646 Impact factor: 5.221
Figure 1Applications and biochemical processes in which 1,2-DHB have been studied.
pKa values for the hydroxyl group reported for different DHBs.
| 1,2-dihydroxybenzene (catechol) | 9.14 | 13.80 | Nurchi et al., |
| 9.15 | 11.23 | Timberlake, | |
| 9.21 | 11.70 | Antikainen and Witikainen, | |
| 9.22 | 13.00 | Avdeef et al., | |
| 9.24 | 13.00 | Charkoudian et al., | |
| 9.27 | 11.49 | Pizer and Babcock, | |
| 9.33 | 12.62 | Park, | |
| 9.34 | 13.24 | Evanko and Dzombak, | |
| 9.37 | 13.70 | Slabbert, | |
| 9.43 | 13.00 | Park, | |
| 3,4- dihydroxybenzoic acid | 8.64 | 13.13 | Beltran et al., |
| 8.67 | 11.74 | Jovanovic et al., | |
| 8.82 | 13.20 | Slabbert, | |
| 1,2-Dihydroxy-4-nitrobenzene (nitrocatechol) | 6.62 | 10.75 | Aydin et al., |
| 6.65 | 10.80 | Avdeef et al., | |
| 6.69 | 10.57 | Pizer and Babcock, | |
| 6.7 | 10.31 | Nurchi et al., | |
| 6.84 | 11.1 | Slabbert, | |
| 3-(3,4-Dihydroxyphenyl)-2-propenoic acid (caffeic acid) | 8.14 | 13.16 | Erdemgil et al., |
| 8.47 | Fazary and Ju, | ||
| 8.672 | 12.6 | Adams et al., | |
| 8.83 | Ozkorucuklu et al., | ||
| 4-(2-aminoethyl)benzene-1,2-diol (dopamine) | 8.86 | 10.31 | Antikainen and Witikainen, |
| 8.89 | 10.41 | Kiss et al., | |
| 8.96 | 10.5 | Rajan et al., | |
| 9.59 | 13.11 | Charkoudian et al., |
Figure 21,2-dihydroxybenzenes studied.
Figure 3Thermodynamic cycle used to determine pKa value for different DHBs.
Method and wavelength used to determine each pKa value for all the DHBs studied.
| 1 | 4-Tert-butylcatechol | pKa1 | 297 | C.S (Baseline to peak) |
| pKa2 | 280 | C.S (Baseline to peak) | ||
| 2 | 4-Methylcatechol | pKa1 | 276, 293 | C.S (Isosbestic point) |
| pKa2 | 272 | C.S (Baseline to peak) | ||
| 3 | 4-Ethylcatechol | pKa1 | 286, 294 | D.S (1° Der) (Isosbestic point) |
| pKa2 | 275 | C.S (Baseline to peak) | ||
| 4 | Hydrocaffeic acid | pKa1 | 206, 230 | C.S (Isosbestic point) |
| pKa2 | 288, 302 | D.S (1° Der) (Isosbestic point) | ||
| pKa3 | 194 | C.S. (Seok) | ||
| 5 | 3,4-Dihydroxyphenylacetic acid | pKa1 | 220, 229 | D.S (1° Der) (Isosbestic point) |
| pKa2 | 216, 230 | D.S (1° Der) (Isosbestic point) | ||
| pKa3 | 210, 223 | D.S (1° Der) (Isosbestic point) | ||
| 6 | Catechol | pKa1 | 275, 293 | C.S (Baseline to peak) |
| pKa2 | 228, 240 | D.S (1° Der) (Isosbestic point) | ||
| 7 | Norepinephrine | pKa1 | 288 | C.S (Seok) |
| pKa2 | 243 | C.S (Seok) | ||
| pKa3 | 311 | C.S (Seok) | ||
| 8 | 1,2,4-Benzenetriol | pKa1 | 284, 308 | D.S (1° Der) (Isosbestic point) |
| pKa2 | 335, 430 | C.S (Isosbestic point) | ||
| pKa3 | 405, 450 | C.S (Isosbestic point) | ||
| 9 | Caffeic acid | pKa1 | 325, 360 | D.S (1° Der) (Isosbestic point) |
| pKa2 | 245, 270 | D.S (1° Der) (Isosbestic point) | ||
| pKa3 | 262, 280 | D.S (1° Der) (Isosbestic point) | ||
| 10 | Dopamine | pKa1 | 287 | C.S (Baseline to peak) |
| pKa2 | 260 | C.S (Baseline to peak) | ||
| 11 | 4-Chlorocatechol | pKa1 | 233, 243 | D.S (2° Der) (Isosbestic point) |
| pKa2 | 261, 292 | D.S (1° Der) Zero Crossing | ||
| 12 | Epinephrine | pKa1 | 287 | C.S (Seok) |
| pKa2 | 287 | C.S (Seok) | ||
| 13 | 3,4-Dihydroxybenzaldehyde | pKa1 | 206, 214 | D.S (1° Der) (Isosbestic point) |
| pKa2 | 246, 256 | C.S (Isosbestic point) | ||
| 14 | 3,4-Dihydroxybenzoic acid | pKa1 | 300, 310 | D.S (1° Der) (Isosbestic point) |
| pKa2 | 205, 216 | D.S (1° Der) (Isosbestic point) | ||
| pKa3 | 265, 277 | C.S (Isosbestic point) | ||
| 15 | 3,4-Dihydroxybenzylamine | pKa1 | 235, 250 | C.S (Isosbestic point) |
| pKa2 | 207, 216 | D.S (1° Der) (Isosbestic point) | ||
| pKa3 | 214, 220 | D.S (1° Der) (Isosbestic point) | ||
| 16 | 3,4-Dihydroxybenzonitrile | pKa1 | 252, 266 | C.S (Isosbestic point) |
| pKa2 | 250, 260 | C.S (Isosbestic point) | ||
| 17 | 4-Nitrocatechol | pKa1 | 258, 265 | D.S (1° Der) (Isosbestic point) |
| pKa2 | 294, 340 | C.S (Isosbestic point) | ||
| 18 | Adrenalone | pKa1 | 281, 306 | C.S (Isosbestic point) |
| pKa2 | 253, 280 | C.S (Isosbestic point) | ||
| pKa3 | 264, 290 | C.S (Isosbestic point) | ||
| 19 | 3,4-Dihydroxyphenylalanine | pKa1 | 208, 232 | C.S (Isosbestic point) |
| pKa2 | 244 | C.S (Seok) | ||
| pKa3 | 291 | C.S (Seok) | ||
| 20 | Catechin | pKa1 | 286 | C.S (Baseline to peak) |
| pKa2 | 286 | C.S (Baseline to peak) | ||
| pKa3 | 286 | C.S (Baseline to peak) | ||
| 21 | Quercetin | pKa1 | 201, 210 | D.S (1° Der) (Isosbestic point) |
| pKa2 | 330, 360 | C.S (Isosbestic point) | ||
| pKa3 | 272, 290 | C.S (Isosbestic point) | ||
| 22 | Chlorogenic acid | pKa1 | 216, 226 | D.S (1° Der) (Isosbestic point) |
| pKa2 | 335, 357 | D.S (2° Der) (Isosbestic point) | ||
| 23 | Isoprenaline | pKa1 | 287 | C.S (Baseline to peak) |
| pKa2 | 221, 241 | D.S (1° Der) (Isosbestic point) | ||
| 24 | Nordihydroguaiaretic acid | pKa1 | 288 | C.S (Seok) |
.
pKa values obtained by spectrophotometric method.
| 1 | 4- | 8.83 ± 0.02 | 13.93 ± 0.05 | – |
| 2 | 4-Methylcatechol | 9.36 ± 0.01 | 13.49 ± 0.06 | – |
| 3 | 4-Ethylcatechol | 8.32 ± 0.03 | 13.53 ± 0.05 | – |
| 4 | 3,4-Dihydroxydihydrocinnamic acid | 4.86 ± 0.07 | 6.97 ± 0.02 | 11.75 ± 0.01 |
| 5 | 3,4-Dihydroxyphenylacetic acid | 5.18 ± 0.04 | 10.04 ± 0.07 | 12.01 ± 0.04 |
| 6 | Catechol | 8.83 ± 0.03 | 13.07 ± 0.05 | – |
| 7 | Norepinephrine | 8.63 ± 0.06 | 10.60 ± 0.08 | 12.94 ± 0.03 |
| 8 | 1,2,4-Benzenetriol | 9.24 ± 0.05 | 11.04 ± 0.04 | 12.91 ± 0.03 |
| 9 | Caffeic acid | 3.95 ± 0.03 | 8.47 ± 0.04 | 12.56 ± 0.05 |
| 10 | Dopamine | 8.91 ± 0.02 | 10.62 ± 0.06 | 12.67 ± 0.04 |
| 11 | 4-Chlorocatechol | 7.90 ± 0.02 | 10.35 ± 0.03 | – |
| 12 | Epinephrine | 8.63 ± 0.04 | 10.90 ± 0.05 | 12.61 ± 0.07 |
| 13 | 3,4-Dihydroxybenzaldehyde | 8.76 ± 0.05 | 11.77 ± 0.07 | — |
| 14 | 3,4-Dihydroxybenzoic acid | 3.17 ± 0.09 | 9.10 ± 0.08 | 11.77 ± 0.05 |
| 15 | 3,4-Dihydroxybenzylamine | 5.67 ± 0.08 | 8.85 ± 0.06 | 12.50 ± 0.04 |
| 16 | 3,4-Dihydroxybenzonitrile | 6.47 ± 0.02 | 11.71 ± 0.05 | – |
| 17 | 4-Nitrocatechol | 5.93 ± 0.05 | 11.05 ± 0.04 | – |
| 18 | Adrenalone | 4.34 ± 0.04 | 6.43 ± 0.06 | 11.85 ± 0.02 |
| 19 | Dopa | 2.06 ± 0.06 | 8.55 ± 0.06 | 9.93 ± 0.03 |
| 20 | Catechin | 8.67 ± 0.07 | 9.37 ± 0.05 | 11.60 ± 0.02 |
| 21 | Quercetin | 6.76 ± 0.04 | 9.10 ± 0.03 | 11.26 ± 0.05 |
| 22 | Chlorogenic acid | 3.36 ± 0.05 | 8.10 ± 0.04 | 11.51 ± 0.04 |
| 23 | Isoprenaline | 8.24 ± 0.07 | 9.99 ± 0.06 | – |
| 24 | Nordihydroguaiaretic acid | 9.38 ± 0.04 | – | – |
Comparison of pKa values obtained experimentally and computationally with different solvation models.
| Catechol | 8.83 | 8.77 | 8.58 | 8.82 |
| 4-Nitrocatechol | 5.93 | 5.58 | 5.13 | 6.10 |
| 4-Ethylcatechol | 8.29 | 8.44 | 8.89 | 8.20 |
Figure 4Correlation diagram of pKa values for different DHBs substituted on 4-position obtained experimentally and computationally.
Figure 5DHBs labels used in this paper.
pKa values obtained for different DHBs determined by computational method and the Hammett constant (σ) of each substituent on 4 position.
| 1 | 4- | 8.24 | 13.51 | – | −0.2 |
| 2 | 4-Methylcatechol | 9.23 | 13.33 | – | −0.17 |
| 3 | 4-Ethylcatechol | 8.29 | 13.42 | – | −0.15 |
| 4 | 3,4-Dihydroxydihydrocinnamic acid | 6.83 | 11.76 | 4.88 | −0.07 |
| 5 | 3,4-Dihydroxyphenylacetic acid | 10.09 | 12.07 | 4.98 | |
| 6 | Catechol | 8.82 | 13.07 | – | 0 |
| 7 | Norepinephrine | 13.41 | 8.59 | 10.41 | 0.09 |
| 8 | 1,2,4-Benzenetriol | 9.26 | 11.13 | 12.60 | −0.37 |
| 9 | Caffeic acid | 12.50 | 8.50 | 3.92 | 0.09 |
| 10 | Dopamine | 13.7 | 8.66 | 11.01 | 0.17 |
| 11 | 4-Chlorocatechol | 8.13 | 10.41 | – | 0.23 |
| 12 | Epinephrine | 13.08 | 8.65 | 10.89 | 0.3 |
| 13 | 3,4-Dihydroxybenzaldehyde | 11.78 | 8.71 | – | 0.42 |
| 14 | 3,4-Dihydroxybenzoic acid | 11.79 | 9.11 | 3.22 | 0.45 |
| 15 | 3,4-Dihydroxybenzylamine | 13.07 | 5.62 | 9.01 | 0.53 |
| 16 | 3,4-Dihydroxybenzonitrile | 11.79 | 6.54 | – | 0.66 |
| 17 | 4-Nitrocatechol | 11.15 | 6.10 | – | 0.78 |
| 18 | Adrenalone | 11.96 | 5.16 | 7.24 | |
| 19 | Dopa | 13.6 | 8.86 | 2.31/10.2 | |
| 20 | Catechin | 8.61 | 9.38 | 11.61 | |
| 21 | Quercetin | 6.78 | 11.56 | 9.17 | |
| 22 | Chlorogenic acid | 11.53 | 8.11 | 3.43 | |
| 23 | Isoprenaline | 8.52 | 10.06 | ||
| 24 | Nordihydroguaiaretic acid | 9.30 | 14.31 | ||
This compound was deprotonated in two groups in the substituent.
Figure 6Example of the equilibrium associated to the pKa for the first hydroxyl deprotonation of DHBs substituted with EDG and EWG.
Figure 7Effect of the intramolecular hydrogen bond in the pKa calculations.